CORRADO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.333
EU - Europa 3.087
AS - Asia 676
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.107
Nazione #
US - Stati Uniti d'America 3.314
IE - Irlanda 877
SE - Svezia 803
CN - Cina 515
IT - Italia 315
UA - Ucraina 277
DE - Germania 224
PL - Polonia 178
FI - Finlandia 131
GB - Regno Unito 108
SG - Singapore 84
FR - Francia 80
IN - India 46
BE - Belgio 45
RU - Federazione Russa 18
CA - Canada 17
VN - Vietnam 12
NL - Olanda 9
CZ - Repubblica Ceca 5
IR - Iran 5
ES - Italia 4
RO - Romania 4
AU - Australia 3
EC - Ecuador 3
JP - Giappone 3
AT - Austria 2
BD - Bangladesh 2
CR - Costa Rica 2
IL - Israele 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HK - Hong Kong 1
KH - Cambogia 1
KR - Corea 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.107
Città #
Dublin 876
Chandler 643
Jacksonville 574
Nyköping 431
Beijing 224
Ashburn 219
Warsaw 170
Boardman 160
Ann Arbor 157
Princeton 129
Cambridge 127
Messina 113
Medford 110
Dearborn 106
Des Moines 99
Woodbridge 61
Singapore 51
Brussels 45
Shenyang 39
Jinan 38
Wilmington 36
Bremen 35
Catania 33
Los Angeles 30
Hyderabad 28
Hebei 25
Lancaster 25
Nanjing 24
Zhengzhou 24
San Mateo 21
Washington 20
Tianjin 17
Houston 16
New York 16
Ningbo 15
Seattle 15
Haikou 14
Auburn Hills 12
Dong Ket 12
Hangzhou 12
Taizhou 12
Helsinki 11
Ottawa 11
Pune 10
Nanchang 9
Milan 8
Viagrande 8
Augusta 7
Changsha 7
Munich 7
Norwalk 7
Jiaxing 6
Lanzhou 6
London 6
Turin 6
Clearwater 5
Falls Church 5
Guangzhou 5
Leawood 5
Ardabil 4
Hefei 4
Kraków 4
Mountain View 4
Poznan 4
Trecastagni 4
Amsterdam 3
Brno 3
Cagliari 3
Edinburgh 3
Fuzhou 3
Las Vegas 3
Mumbai 3
Novokuznetsk 3
Paterno 3
Phoenix 3
Polverigi 3
Quito 3
Rho 3
Saint Petersburg 3
Taiyuan 3
Andover 2
Boston 2
Cairo Montenotte 2
Caltagirone 2
Greifswald 2
Jeffries 2
Lentini 2
Luxembourg 2
Mascalucia 2
Monterotondo 2
New Delhi 2
Palermo 2
Redmond 2
San José 2
Siracusa 2
Southwark 2
Tappahannock 2
Tel Aviv 2
Tokyo 2
Tomsk 2
Totale 5.052
Nome #
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 112
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 103
Italian risk factor-based screening for gestational diabetes. 95
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 86
Effects of myo-inositol on glucose variability in women with gestational diabetes 86
Screening for gestational diabetes in Sicily. 83
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 82
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 82
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 80
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 78
Intravaginal vs. intracervical PGE(2) gel first application for labor induction 77
A 45,X MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y- EUCHROMATIN ONTO CHROMOSOME-1 76
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 76
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 75
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 75
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 74
Compliance with hormone replacement therapy in postmenopausal Sicilian women 73
Glucose Tolerance and insulin secretion in pregnancy 72
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 72
Abortività spontanea ed età materna avanzata. 72
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 72
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 71
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 71
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 70
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 69
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 68
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 66
A 45,MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y EUCHROMATIN ONTO CHROMOSOME 1 66
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 65
Celiac disease in pregnancy: not always a relapse 65
Role of urocortin in pregnancy: an update and future perspectives 64
"Anticorpi antifosfolipidi ed aborto ricorrente". 63
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 63
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis 63
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 62
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 62
PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA DURING ASPIRIN TREATMENT 61
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 61
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 61
VARIABILITA' GENOTIPICA E FENOTIPICA DELLA SINDROME DI PATAU.. OSSERVAZIONE DI UN CASO 60
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 60
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 60
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 59
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 59
Differences in body composition between post-menopausal women with and without dyslipidemia. 59
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 59
Prostate-specific antigen in prenatal screening for Down's syndrome 58
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 58
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 58
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 58
Cardiovascular effects of the phytoestrogen genistein 58
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 58
Rupture of the cervix in a sulprostone induced abortion in the second trimester 57
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 57
Diagnosis of celiac disease in pregnancy and puerperium: think about it 56
Midtrimester amniotic fluid adiponectin in normal pregnancy. 56
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 56
Diagnosis of gestational diabetes mellitus: italian perspectives on risk factor based screening 56
Neurokinin B peptide levels in normal pregnancy 55
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 55
Myo-inositol may prevent gestational diabetes in PCOS women 55
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 55
Large placental chorioangioma 54
Gestational glucose intolerance multiple pregnancy 54
Intraperitoneal chemotherapy with mitoxanthrone in ovarian cancer 54
Cardiovascular effects of raloxifene hydrochloride 54
Modalità di prelievo in corso d'amniocentesi ed outcome ostetrico 54
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 53
C-reactive protein as an early predictor of gestational diabetes mellitus 53
A randomised trial of progesterone prophylaxis after midtrimester amniocentesis 53
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 53
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 53
Screening for gestational diabetes in Sicily 52
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 52
How to achieve high-quality oocytes? The key role of myo-Inositol and melatonin 52
Intolleranza glucidica e disordini ipertensivi in gravidanza. 52
Sindrome mano-piede-utero. Descrizione di un caso ad ereditarietà autosomica recessiva. 51
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 51
La disfunzione diastolica nel diabete gestazionale 51
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 50
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 50
I LIVELLI SIERICI DI NGAL NEL PRIMO TRIMESTRE DELLA GRAVIDANZA SONO PREDITTIVI DELL’INSORGENZA DI DIABETE GESTAZIONALE. 50
SULLA MUTAGENICITA' DEL METRONIDAZOLO 49
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 49
Maternal serum PAPP-A as an early marker of obstetric complications? 49
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 49
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 48
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 47
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 47
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 47
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 47
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 47
Gestational weight gain across continents and ethnicity: Systematic review and meta-analysis of maternal and infant outcomes in more than one million women 47
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction 46
The placental growth hormone in Down's syndrome screening 46
TESTICULAR REGRESSION SYNDROME - A CASE-REPORT 46
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 46
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 46
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension 46
Totale 6.100
Categoria #
all - tutte 28.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020907 0 0 10 70 12 114 144 124 45 175 182 31
2020/2021981 113 36 200 45 64 105 56 98 45 109 72 38
2021/2022979 11 155 18 28 35 11 60 37 24 239 105 256
2022/20232.621 181 260 140 171 218 263 15 155 1.094 15 82 27
2023/2024703 54 96 46 97 64 113 16 21 7 46 7 136
2024/2025102 44 34 24 0 0 0 0 0 0 0 0 0
Totale 7.291